- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Schizophrenia-spectrum Diagnosis in Chile
Total 16 results
-
Columbia UniversityNational Institute of Mental Health (NIMH)CompletedSchizophrenia | Psychotic DisorderBrazil, Chile
-
University of ChileWashington University School of Medicine; New York University; Columbia University and other collaboratorsRecruiting
-
University of ChileMinistry of Health, ChileCompletedSchizophrenia | Schizoaffective Disorder | Bipolar DisorderChile
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaKorea, Republic of, United States, Estonia, Italy, Hungary, Bulgaria, Croatia, France, Poland, Thailand, Puerto Rico, Chile, South Africa, Austria, Belgium
-
Hoffmann-La RocheCompletedSchizophreniaGermany, Spain, Turkey, Canada, United States, Netherlands, Chile, Brazil, Taiwan, Poland, Ukraine, Slovakia, Lithuania, Latvia
-
Hoffmann-La RocheCompletedSchizophreniaGermany, Spain, Turkey, Canada, United States, Netherlands, Chile, Brazil, Taiwan, Poland, Ukraine, Slovakia, Lithuania, Latvia
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States, India, South Africa, Estonia, Russian Federation, Mexico, Korea, Republic of, Malaysia, Bulgaria, Hungary, Croatia, Serbia, Poland, Romania, Puerto Rico, Slovakia, Chile, Taiwan, Thailand, Australia, Spain, Argentina, Finlan... and more
-
Boehringer IngelheimActive, not recruitingClinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)SchizophreniaUnited States, Spain, Korea, Republic of, Croatia, Malaysia, Japan, Singapore, Chile, Serbia, Poland, Hungary, Argentina, France, Slovakia, Brazil, Netherlands, Romania, Ukraine
-
Otsuka Pharmaceutical Development & Commercialization...CovanceCompletedSchizophreniaSpain, Korea, Republic of, United States, Russian Federation, Chile, Estonia, Finland, Mexico, Hungary, Bulgaria, Croatia, Serbia, France, Poland, Romania, Thailand, Puerto Rico, Slovakia, Taiwan, Australia, India, Argentina, South... and more
-
Boehringer IngelheimRecruitingSchizophreniaKorea, Republic of, Canada, United States, Taiwan, United Kingdom, Chile, Serbia, Brazil, China, Colombia, Germany, Greece, Italy, Japan, Mexico, Norway, Poland, Sweden, Spain, Argentina, Croatia, France, Slovakia, Denmark, Malaysia, Czechia and more
-
SunovionCompletedSchizophrenia | Schizoaffective DisorderUnited States, Israel, Chile, South Africa, Argentina, Brazil, Croatia, Thailand
-
Solvay PharmaceuticalsWyeth is now a wholly owned subsidiary of Pfizer; H. Lundbeck A/STerminatedSchizophreniaUnited States, Argentina, Canada, Chile, Czech Republic, Estonia, Finland, Germany, Hungary, Latvia, Lithuania, Peru, Slovakia, South Africa
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH); Yale University; OrygenRecruitingPsychosis | Remission | Conversion | Clinical High RiskUnited States, United Kingdom, Canada, Italy, Australia, Chile, China, Denmark, Germany, Hong Kong, Korea, Republic of, Singapore, Spain, Switzerland
-
Karuna TherapeuticsRecruitingPsychosis Associated With Alzheimer's DiseaseUnited States, Korea, Republic of, Chile, Greece, Poland
-
GuerbetCompletedCentral Nervous System Diseases | Diagnostic Self EvaluationUnited States, Korea, Republic of, Argentina, Spain, France, Austria, Germany, Brazil, Chile, Italy, United Kingdom
-
ACADIA Pharmaceuticals Inc.CompletedDementia-related PsychosisUnited States, Spain, Poland, Ukraine, Chile, Czechia, United Kingdom, Bulgaria, France, Germany, Italy, Serbia, Slovakia